Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Essex Bio-Technology Limited (HK:1061)
HKEX:1061
Essex Bio-Technology (1061) Stock Price & Analysis
0 Followers
1061 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$1.92 - HK$3.39
Previous CloseHK$2.34
Volume102.00K
Average Volume (3M)174.07K
Market Cap
HK$1.33B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)4.8
Beta0.47
Next Earnings
Aug 13, 2024EPS EstimateN/A
Last Dividend Ex-Date
May 30, 2024Dividend Yield3.85%
Share Statistics
EPS (TTM)0.48
Shares Outstanding567,540,000
10 Day Avg. Volume330,000
30 Day Avg. Volume174,075
Standard Deviation0.11
R-Squared0.24
Alpha-0.00007
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Essex Bio-Technology News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
2.51% Mutual Funds
0.05% Other Institutional Investors
97.44% Public Companies and
Individual Investors
1061 FAQ
What was Essex Bio-Technology Limited’s price range in the past 12 months?
Essex Bio-Technology Limited lowest stock price was HK$1.92 and its highest was HK$3.39 in the past 12 months.
What is Essex Bio-Technology Limited’s market cap?
Currently, no data Available
When is Essex Bio-Technology Limited’s upcoming earnings report date?
Essex Bio-Technology Limited’s upcoming earnings report date is Aug 13, 2024 which is in 37 days.
How were Essex Bio-Technology Limited’s earnings last quarter?
Essex Bio-Technology Limited released its earnings results on Mar 18, 2024. The company reported HK$0.186 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.186.
Is Essex Bio-Technology Limited overvalued?
According to Wall Street analysts Essex Bio-Technology Limited’s price is currently Overvalued.
Does Essex Bio-Technology Limited pay dividends?
Essex Bio-Technology Limited pays a Annually dividend of HK$0.04 which represents an annual dividend yield of 3.85%. See more information on Essex Bio-Technology Limited dividends here
What is Essex Bio-Technology Limited’s EPS estimate?
Essex Bio-Technology Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Essex Bio-Technology Limited have?
Essex Bio-Technology Limited has 567,540,000 shares outstanding.
What happened to Essex Bio-Technology Limited’s price movement after its last earnings report?
Essex Bio-Technology Limited reported an EPS of HK$0.186 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.476%.
Which hedge fund is a major shareholder of Essex Bio-Technology Limited?
Currently, no hedge funds are holding shares in HK:1061
---
Essex Bio-Technology Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.52%
12-Months-Change
Fundamentals
Return on Equity
15.06%
Trailing 12-Months
Asset Growth
4.25%
Trailing 12-Months
Company Description
Essex Bio-Technology Limited
Essex Bio-Technology Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in developing, manufacturing, and selling of biopharmaceutical products. The biopharmaceutical products are developed for the treatment and healing of surface wounds and eye wounds. The company reports in two segments that are Ophthalmic products and Surgical products. It focuses on the Ophthalmology and surgical arena of topical (skin) surface wounds primarily covering dermatology, stomatology, obstetrics, and gynecology. The company's products include Beifushu Eye Drops, Beifushu Gel, Beifuji Spray, Lodized Lecithin Capsule, Medictop, and others. All of the company revenues are generated from the People's republic of china.
---
Technical Analysis
---